16 Bit Announces FDA De Novo Marketing Authorization of Rho™, an AI-enabled Opportunistic Pre-Screen for Low Bone Mineral Density on Standard X-Rays
/PRNewswire/ – 16 Bit Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted a De Novo marketing authorization for Rho™, an…